ICU Medical, Inc. (ICUI) Company Profile & Statistics

ICU Medical, Inc.
ICUI
(Nasdaq - US)
Closed
176.71
-1.84 (-1.03%)
in:usd•As of: Nov 08, 2024 15:59 UTC -5
Open
180.12
High
180.70
Low
176.51

About ICU Medical, Inc.

CEO

Vivek Jain

Headquarters

951 calle amanecer

san clemente, ca 92763, united states

Auditor

Deloitte & Touche LLP

Employees

14,000

Share Holders

Website

www.icumed.com

Industry

medical specialties

Sector

health technology

Company Overview

ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.

ICU Medical, Inc. Statistics

Valuation Measures

Market Capitalization ²	4.32B
Enterprise Value	5.62B
Enterprise Value/EBITDA (ttm)	23.32
Price to Earnings Ratio (ttm)	41.73
Price to Book (mrq)	2.14
Price to Sales (ttm)	1.90
Price to Cash (ytd)	11.69

Profitability

Gross Margin (ttm)	32.47%
Operating Margin (ttm)	4.53%
Profit Margin (ttm)	-3.04%
Return on Equity (ttm)	5.01%
Return on Invested Capital (ttm)	-1.95%
Return on Assets (ttm)	2.41%

Income Statement

Revenue (ttm)	2.30B
Revenue Per Share (ttm)	94.34
Gross Profit (ttm)	748.18M
EBITDA (ttm)³	240.92M
Net Income Avi to Common (ttm)	-70.79M
Diluted EPS (ttm)	-2.92

Share Statistics

Beta (5Y Monthly)	0.66
52-Week Change	103.91%
S&P500 52-Week Change	36.80%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	24.43M
Dividend Yield	0.00%
Float ⁴	22.79M
% Held by Insiders	6.70%
% Held by Institutions	96.10%

Balance Sheet

Total Cash (mrq)	302.65M
Total Cash Per Share (mrq)	12.39
Total Debt (mrq)	1.61B
Total Debt/Equity (mrq)	78.80%
Current Ratio (mrq)	2.41%
Quick Ratio (mrq)	1.08%
Book Value Per Share (mrq)	83.43

Cash Flow

Operating Cash Flow Per Share (ytd)	5.24
Free Cash Flow (ytd)	93.05M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ICU Medical, Inc.

Trade With A Regulated Broker